REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
20/07/2026
Voltar para busca
Dado oficial do USPTO
SYSNIB
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SYSNIB
ST13
US500000079292224Classe
5, 9, 10, 42, 44
Pedido
79292224
Registro
6422359
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
20/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 42, 44
Data de depósito
18/06/2020
Data de registro
20/07/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/07/2021
Última transação
20/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
JP
Examinador
PARKS, KIMBERLY L
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
NITTO BOSEKI, CO., LTD.
Representantes
M. Scott Alprin Alprin Law Offices, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of cancer; drugs for medical purposes for the treatment of cancer; medicines for human purposes for the treatment of cancer; in vitro diagnostic preparations for medical purposes; diagnostic preparations for medical purposes; diagnostic test reagents for medical purposes; biochemical preparations for medical purposes for the treatment of cancer; biological reagents for medical purposes; biological preparations for medical purposes for the treatment of cancer; chemical reagents for medical purposes; reagents for medical purposes; clinical diagnostic reagents for medical purposes; diagnostic agentspreparations and substances for medical purposes; chemical preparations for medicinal purposes for the treatment of cancer; antibodies for medical purposes for the treatment of cancer; diagnostic biomarker reagents for medical purposes
Classe 9
Laboratory apparatus and instruments for treating biological tissue for pathological studies; laboratory apparatusinstruments and their structural parts and fittings for treating biological tissue not for medical purposes; laboratory apparatus and instruments for sample pre-treatment system and sample preparation system; measuring and testing machines and instruments for genetic analysis; measuring or testing machines and instrumentsflow cytometerscell-sortersimaging cytometersimaging analyzers; biological cell testing apparatus for laboratory purposes; biological tissue testing apparatus for laboratory purposes
Classe 10
Diagnostic apparatus for medical purposes for testing cancer cellscancerous nucleilymphocytesnucleoproteinDNARNA; biological cell testing apparatus for medical and medical diagnostic purposes; biological tissue testing apparatus for medical and medical diagnostic purposes; medical apparatus for clinical diagnosis of cancer; medical apparatus for pathologic diagnosis; medical apparatus and instruments for pathologic examination
Classe 42
Genetic testing for scientific research purposes; developmenttestinginspection for quality control purposesresearch of pharmaceuticals and biological preparations; testing of pharmaceuticalsinspection for quality control purposes and medical research in the fields of medical treatment method and technology; medical research; biological research; chemistry serviceschemistry consultationresearch in the fields of biologyoncology and pathology; chemical and biological laboratory servicesbiologicaloncological and pathological research; laboratory research and analysis services in the fields of biologyoncology and pathology
Classe 44
Clinical pathological examination and cytological diagnostics for medical purposes; medical testing for diagnostic purposes; medical testing for disease prediction; pathological examination for medical purposes and providing medical information relating thereto; genetic testing for medical purposes; medical and health services relating to DNAgenetics and genetic testing; medical services; medical information
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/10/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/02/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/12/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
17/11/2021
FIMP
FINAL DISPOSITION PROCESSED
17/11/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/10/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
20/07/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/05/2021
PUBO
PUBLISHED FOR OPPOSITION
04/05/2021
GPNX
NOTIFICATION PROCESSED BY IB
02/05/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/04/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
14/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/04/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/03/2021
RFNT
REFUSAL PROCESSED BY IB
14/11/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/10/2020
RFRR
REFUSAL PROCESSED BY MPU
28/10/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/10/2020
CNRT
NON-FINAL ACTION WRITTEN
04/10/2020
DOCK
ASSIGNED TO EXAMINER
22/09/2020
MAFR
APPLICATION FILING RECEIPT MAILED
25/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/08/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/08/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SYSNIB ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.